TOKYO (Reuters) - A group of Takeda Pharmaceutical Co Ltd shareholders trying to build support to block the $62 billion acquisition of London-listed Shire Plc failed to get a proposal passed at the drugmaker's annual general meeting (AGM) on Thursday.
from Reuters: Business News https://ift.tt/2N3RuxL
via IFTTT
0 comments:
Post a Comment